Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers
Clinical trial NCT03645746 · COMPLETED
Trial details
- NCT number
- NCT03645746
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-09-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.